Dr. Armand Bouzaglou, MD

Dr. Bouzaglou practices at Westwood Eye Surgical Institute, Inc. in Beverly Hills, California.

Dr. Bouzaglou's NPI, 1457430399, was assigned on November 2, 2006. Dr. Bouzaglou holds California license HG26098.

Dr. Bouzaglou's primary practice is Westwood Eye Surgical Institute, Inc., at 8900 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 474-2010.

Dr. Bouzaglou's primary practice is Westwood Eye Surgical Institute, Inc. in Beverly Hills, California. The medical group on file is Beverly Hills Cancer Center. Dmand AI also links Dr. Bouzaglou to 2 more group practices and clinics, 2 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bouzaglou practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Bouzaglou's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Bouzaglou's licenses on file in 2 states: California and Colorado.

CMS data shows 25 Medicare services from Dr. Bouzaglou across 1 procedure code in 2024, all of them office visits, for 42 Medicare patients. Medicare paid $2,741 for them. Every service was in an office.

CMS counts 42 Medicare patients who saw Dr. Bouzaglou in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 69% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bouzaglou's median patient age at 66, with 60% women.

In 2024, Dr. Bouzaglou wrote 71 Medicare Part D claims for 29 patients. 93% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $152 in total drug cost. In 2023, CMS named 28 claims across 1 drug.

Dr. Bouzaglou accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Dr. Bouzaglou from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. INSYS Therapeutics Inc paid the most, $187.